UCSF Radiation Oncology

What UCSF Radiation Oncology does

UCSF Radiation Oncology is a clinical, research, and teaching department within UCSF Health and the University of California system, operating as part of the public University of California governance structure (The Regents of the University of California). The department provides radiation therapy for approximately 2,500 new adult and pediatric cancer patients per year across four physical sites in San Francisco (Parnassus, Mount Zion, Mission Bay) and Berkeley, using five gantry-based linear accelerators and a comprehensive equipment portfolio that includes CyberKnife, Gamma Knife, TomoTherapy, TrueBeam, and Versa HD systems. Service lines span external beam radiation therapy, intensity-modulated and image-guided radiation therapy, stereotactic radiosurgery and body radiotherapy, HDR and LDR brachytherapy, intraoperative radiation therapy, total body irradiation, hyperthermia, proton therapy for ocular tumors, and low-dose radiation for osteoarthritis.

The department's technology and clinical programs are paired with a substantial research enterprise covering treatment-planning optimization, MR-guided radiotherapy, FLASH radiotherapy, radiobiology, deep-learning applications in imaging (synthetic CT, MRI-based tumor mapping, motion-resolved 4D MRI), and AI initiatives including Julian Hong's Project IMPACT and the Weill Cancer Hub West consortium. Revenue is generated through two streams: billable patient-care services reimbursed by Medicare, Medicaid, and commercial insurance across multiple modalities, and externally funded research grants from federal agencies (NIH, DoD CDMRP), foundations (Sontag), and cooperative groups (NRG Oncology). Distribution is direct via provider referrals and patient scheduling, supplemented by a partnership with John Muir Health at the Berkeley Outpatient Center. Educational programs include an ACGME-accredited medical residency and fellowship, a CAMPEP-accredited physics residency, and training of approximately 25 pre- and post-doctoral fellows.

Name

UCSF Radiation Oncology

Legal name

The Regents of the University of California

Website

https://radonc.ucsf.edu

Company type

Public

Founded year

1978

Operating status

Operating

Headcount range

1–10 employees

Short description

UCSF Radiation Oncology is a public university department operating five linear accelerators across four San Francisco Bay Area sites, treating ~2,500 new cancer patients per year with a full spectrum of radiation modalities while running a sizable research and AI-driven imaging program.

Ownership category

akta.pro rank

Product category

Radiation Oncology / Cancer Treatment Services

NAICS

Diagnostic Imaging Centers (621512)

SIC

Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Radiation Oncology (HLAKAFAC)

akta.pro secondary industries

Radiation Therapy Planning & Simulation Imaging (CT Sim/MR Sim) (HLAHABAH), Radiation Dose Management & Analytics (HLACALAH), Nuclear Medicine Clinical Services & Therapy Centers (HLAIAGAI)

Keywords

• Radiation oncology services
• Cancer treatment
• Stereotactic radiosurgery
• Proton therapy
• Brachytherapy

Headquarters

HQ city

San Francisco

HQ country

United States

HQ region

North America

Offices5 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Infrastructure, Operations

Revenue model

1. Patient Care Services: Billable healthcare services including radiation oncology treatments, procedures, and clinical consultations covered by health insurance, Medicare, and Medicaid.
2. Research Grants and Funding: Federal and state government grants, foundation funding, and private research gifts supporting clinical and basic science research programs.

Pricing tiers

Go-to-market motion1 record

Distribution channels6 records

Marketing channels7 records

Core offering

UCSF Department of Radiation Oncology provides comprehensive radiation therapy services for adult and pediatric cancer patients across multiple San Francisco Bay Area sites. It delivers precision radiotherapy using linear accelerators, CyberKnife, Gamma Knife, TomoTherapy, brachytherapy, proton therapy, and a range of specialized techniques (IMRT, IGRT, SRS, SBRT, TBI, IORT, hyperthermia), supported by imaging, treatment planning systems, and an ACGME-accredited medical residency program and CAMPEP-accredited physics residency program.

Product overview

UCSF Radiation Oncology is a comprehensive cancer treatment department offering a broad portfolio of radiation therapy services and technologies. The department operates multiple treatment equipment systems (CyberKnife, Gamma Knife, TomoTherapy, TrueBeam, Versa HD) for various radiation delivery approaches. Treatment services include external beam radiation therapy (EBRT), intensity-modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), brachytherapy (HDR/LDR), intraoperative radiation therapy (IORT), total body irradiation (TBI), hyperthermia, and proton therapy for ocular tumors. The department also provides specialized services including low-dose radiation therapy for osteoarthritis and the SDX breath monitoring system for motion management. Educational programs include Medical Residency & Fellowship training and Physics Residency programs. A major new proton therapy center is under development at the Dogpatch Power Station. The department is integrating AI and machine learning technologies for personalized cancer treatment through Project IMPACT and various deep learning applications in imaging and treatment planning.

Differentiator

Problem solved

Functional benefit

Products and services

• Brachytherapy (HDR and LDR)
• External Beam Radiation Therapy (EBRT)

Quantifiable outcome

• US News and World Report Best Hospitals Honor Roll recognition
• +1 more outcomes

Named customers14 records

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability10 records

Feature15 records

Partnerships

Seven partnerships are on record, tiered flagship, core and minor.

• NRG OncologyflagshipStrategic or Co-development Partner · 1 March 2026Dr. David Raleigh appointed Translational Science Co-Vice Chair of NRG Brain Tumor Committee. Department faculty lead multiple NRG cooperative group trials.
• Weill Cancer Hub WestflagshipStrategic or Co-development Partner · 1 May 2025$200 million initiative to build AI systems integrating clinical and biological data for precise, personalized cancer treatments. Julian Hong's Project IMPACT selected for funding.
• John Muir HealthcoreChannel Partner/ Reseller/ DistributorJohn Muir Health partnership provides radiation oncology services at the Berkeley Outpatient Center location, extending UCSF Radiation Oncology's regional reach in the East Bay area.
• UC Davis - Crocker National LaboratorycoreStrategic or Co-development PartnerCollaborative proton therapy program for ocular melanomas, with treatment delivered at the Crocker National Laboratory using the cyclotron facility.
• University of California Health SystemcoreStrategic or Co-development PartnerMulti-institutional collaboration analyzing mental health and cancer outcomes data across UC-affiliated hospitals, including over 370,000 adult cancer patients.
• NRG Oncology Biospecimen BankcoreStrategic or Co-development PartnerNRG Biospecimen Bank at UCSF supports national clinical trial research with archival biobank specimens.
• Stanford University - Medical PhysicsminorStrategic or Co-development PartnerCollaboration with Stanford's Guillem Pratx, PhD for medical physics research symposium and FLASH radiotherapy discussions.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• UC Davis Radiation Oncology: Partner in the Crocker National Laboratory ocular proton program and fellow UC-system academic radiation oncology program. Operates within the same UC governance and Northern California referral market, with overlapping service lines.
• Cedars-Sinai Radiation Oncology: Major Los Angeles academic radiation oncology program with comparable technology portfolio and research mission. Faculty members like Wensha Yang previously served at Cedars-Sinai, illustrating direct lateral talent flow.
• Stanford Radiation Oncology: Stanford's radiation oncology program operates within the same San Francisco Bay Area academic medicine ecosystem, offering comparable radiation modalities (SBRT, SRS, brachytherapy, proton therapy) and competing for the same patient referrals and faculty talent.
• UCLA Radiation Oncology: Fellow University of California radiation oncology program operating within a large academic medical center. Vice Chair of Medical Physics Ke Sheng previously served as tenured professor at UCLA, demonstrating direct program-to-program talent flow.

Broad incumbents

• Johns Hopkins Radiation Oncology: NCI-designated academic radiation oncology program with comparable subspecialty expertise, brachytherapy and proton therapy programs, and clinical trial leadership through NRG Oncology.
• Memorial Sloan Kettering Cancer Center Radiation Oncology: One of the world's leading academic radiation oncology programs, operating within a comprehensive cancer center with comparable subspecialty expertise, clinical trial infrastructure, and technology portfolio.
• UCSF Helen Diller Family Comprehensive Cancer Center: The parent cancer center within UCSF provides multidisciplinary oncology services that integrate with radiation oncology. Comparable as an academic NCI-designated cancer center, though it spans all oncology specialties rather than radiation specifically.
• MD Anderson Cancer Center Radiation Oncology: The flagship U.S. academic radiation oncology program, offering comparable technology breadth (proton therapy, Gamma Knife, CyberKnife, SBRT) and serving as a research and training benchmark for programs like UCSF.
• Massachusetts General Hospital Radiation Oncology: Harvard-affiliated academic radiation oncology program with a long-established proton therapy center and comprehensive technology portfolio, providing a comparable East Coast benchmark for UCSF's clinical and research mission.
• City of Hope Radiation Oncology: NCI-designated comprehensive cancer center with a large radiation oncology program including proton therapy, competing with UCSF for complex California referrals and clinical trial enrollment.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/UCSFRadOnc
• YouTubeyoutube.com/@UCSFRadiationOncology
• LinkedInlinkedin.com/company/ucsf-radiation-oncology

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles18 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about UCSF Radiation Oncology